Ischaemic heart disease is the leading cause of mortality worldwide. Acidosis is the main mediator of ischaemia and shielding against it might be possible. In this study, we characterize the nature of interaction between the regulatory domain of cardiac troponin C and the A162H-substituted cardiac troponin I (cTnI) that confers protection against acidosis.
Introduction
Ischaemic heart disease accounts for almost half of the deaths caused by cardiovascular diseases worldwide, which is the number one cause of death. 1 Ischaemia results from reduced blood flow to the cardiac cells that deprives them of oxygen and causes accumulation of ions and products of metabolism; this results in the reduction of force, the increase of arrhythmias, and ultimately cell death. The fall in force during myocardial ischaemia is caused by the reduced Ca 2+ sensitivity of the contractile protein troponin C 2 (cTnC), as the pH in the heart muscle falls from normal values of 7.4 to values of 6.2 or lower. 3 In contrast to cardiac muscle, the force development of skeletal muscle is not compromised in an acidic environment. The explanation of this difference in sensitivity to acidosis has been the object of investigation in a number of studies 4 -7 and it was found that the thin filament protein, troponin I (TnI), plays a major role in the underlying mechanism. TnI forms part of the troponin complex, which regulates contraction in a Ca 2+ -dependent manner. In the cardiac system, the switch region of TnI comprising residues 147-163 interacts with the N terminal, Ca 2+ -binding domain of troponin C (cNTnC); this association causes the dissociation of cardiac TnI (cTnI) from actin and the movement of tropomyosin that exposes the myosin-binding sites on actin, leading to cross-bridge formation and generation of force. 7, 8 Among the differences in sequences between skeletal TnI (sTnI) and cTnI isoforms, a single residue was identified 9 to be responsible for the † Present address. Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London SE1 1UL, UK.
change in sensitivity under acidic environment: H130 in the slow (ssTnI) and fast skeletal isoforms. ssTnI is the major isoform in foetal and neonatal hearts, but it is replaced by adult cTnI shortly after birth 7 ; it is also present in adults in slow-twitch muscles like the soleus muscles. The A162H substitution in the adult isoform of cTnI has been studied at different levels of biological organization to probe its effects on cardiac performance. It has been shown that the A162H substitution restores the Ca 2+ -sensitivity at pH 6.5 to that at pH 7 in a reconstituted human cardiac troponin-tropomyosin actomyosin system, and that the reverse mutation, H130A, in sTnI reduces Ca 2+ -sensitivity to that of the cardiac system at low pH. 9 Using a transgenic mouse model, it was demonstrated ex vivo that the histidine substitution A164H, corresponding to human A162H, causes retention of contractility after exposure to ischaemia mimetic solution in membrane-intact adult cardiac myocytes and improves diastolic performance of isolated hearts after perfusion with acidic buffer. In an in vivo animal model, transgenic A164H mice showed more resistance to hypoxic and ischaemic challenges, maintaining contractility and improving survival compared with non-transgenic mice. 10, 11 Different molecular mechanisms have been proposed for the improvement in myocardial performance by the cTnI A162H substitution. One suggests that the increased positive charge of the histidine during intracellular acidosis leads to stronger interaction with glutamate or aspartate residues in cTnC, 9 or to weaker interactions with arginine or lysine residues in actin, or a combination. The other proposes the direct enhancement of sarcomeric Ca 2+ activation, as basal and peak Ca 2+ levels are lower in A164H transgenic myocytes. 10 The interaction of cNTnC with sTnI, naturally containing H130, has been studied by nuclear magnetic resonance (NMR) spectroscopy. It was shown that H130 makes electrostatic interactions with cNTnC at low pH 12 and computational analysis predicted that the electrostatic interaction between cTnC and sTnI is four times stronger than the interaction with cTnI.
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This study examines the underlying interactions in the cardiac cTnC-cTnI interface that dictate myocardial improvement by the A162H substitution. We use NMR spectroscopy to study the interaction of Ca 2+ -saturated cNTnC with the switch peptide region of cTnI containing the A162H substitution under normal and acidic conditions, and a longer version containing the native histidine at position 171, downstream from H162. Our results show that the presence of H162 increases the affinity of cTnI for cNTnC at pH 7 and the increase is further enhanced at pH 6. To determine the interactions responsible, we determined the acid dissociation constant (pK a ) for glutamate residues in cNTnC. The results show that E15 and E19 exhibit deviations in their pK a profiles, E15 has a shifted pK a , and E19 shows biphasic pK a curves, and both residues display a common high pK a value that indicates an electrostatic interaction with H162. H171 does not have the same effect as H162, because H171 is too far away to form salt bridges with E15 or E19. Escherichia coli strains as previously described. 14 Two switch cTnI peptides were independently titrated into cNTnC . Ca 2+ at both normal (pH 7) and acidic (pH 6) conditions: (i) the mutated peptide (cTnI 144 -170 A162H) and (ii) the native peptide (cTnI 144 -173 ). Both synthetic peptides were obtained from GL Biochem Ltd (Shanghai, China); the sequences are shown in Table 1 . In the present study, we used a version placing H162 in a middle position to avoid having A162H in a highly flexible C-terminal region.
Methods

Materials and sample conditions
All the NMR samples were 500 mL in volume and consisted of 100 mM KCl, 10 mM imidazole, 10 mM CaCl 2 , 10 mM DTT, and 0.25 mM 2,2-dimethyl-2-silapentane-5-sulfonate-d 6 sodium salt (DSS-d 6 ) as NMR internal reference. The initial concentration of cNTnC for each titration was determined by NMR spectral integration. 15 All the NMR experiments were acquired in a 500 or 600 MHz Varian Inova spectrometers at 308C. The 1D spectra were processed using VNMRJ v. For the titration at pH 6, the initial cNTnC concentration was 126 mM, the cTnI 144 -170 A162H stock concentration was 3.7 mM, and the concentration of mutated peptide at each point was 0, 7, 22, 44, 65, 100, 149, 215, and 342 mM.
For the titration of the native cTnI peptide, the initial concentrations of cNTnC at pH 7 and pH 6 were 146 and 160 mM, respectively; the cTnI 144 Figure 5C for numbering). A separate pH titration was performed for free cTnI 144 -170 A162H in solution ranging from 4.3 to 8.9 for the pK a determination of H162 when the mutated peptide is not in the bound form. In a similar fashion, the pK a of H171 in the native peptide cTnI 144 -173 was determined. The determination of the pK a values was made by using xcrvfit for monophasic curves and Wolfram Mathematica for biphasic curves as previously described.
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The spread of the mean indicates the standard deviation (SD) of the fit.
Results
pH-dependent affinities of cTnI 144 -170
A162H and cTnI 144 -173 for cNTnC . Ca
21
The sequence comparison of the two peptides used in this study is shown in Table 1 . The first peptide is the wild-type cardiac sequence with a naturally occurring histidine at position 171; the second a slightly shorter version without H171 but with alanine 162 mutated to histidine. In order to determine the affinities of the peptides for cNTnC, and to map the changes in binding under acidosis, we performed titrations of each into Ca 2+ -saturated cNTnC at pH 7 and pH 6 and monitored these titrations using 2D 1 H, 15 N correlation NMR spectroscopy. We used calcium-saturating conditions since calcium association with cNTnC is necessary for cTnI 147 -163 switch peptide binding. 21 At low Ca 2+ conditions, resembling diastole, weak or no binding at all is expected for the switch peptide. Figure 1A depicts the NMR CSP for a selected group of backbone NHs of cNTnC upon binding of cTnI 144 -170 A162H under normal and acidic conditions; the spectra showing all of the backbone NHs are shown in the supplementary material (Supplementary material online, Figure S1 ). The chemical shift assignments are as reported previously. 22 The peptide-induced spectral changes are virtually identical under the two sets of conditions. We have used an extended version of the cardiac switch peptide in this study; however, the residues experiencing CSP in cNTnC and the direction of such changes are typical for switch peptide binding and consistent with those observed for shorter versions 22, 23 ; for example, large perturbations for residues L29, G34, G42, E66, G68, T71, and D73 were observed. These large changes were expected since these amino acids are located in the hinge regions of cNTnC which are responsible for the closed-to-open structural transition. 24 The linear fashion of the perturbations is characteristic of a one-to-one binding stoichiometry. Global fitting of the most perturbed residues ( Figure 1B ) results in a dissociation constant of 40 + 11 mM for the binding of cTnI 144 -170 A162H under normal conditions and 10 + 3 mM for binding under acidic conditions. The results indicate that the presence of H162 in cTnI stabilizes the cTnC-cTnI interaction by a factor of 4. In order to investigate whether the naturally occurring H171 plays a similar role in stabilizing this interaction, we determined the dissociation constants for the binding of a slightly longer, native cardiac switch peptide (cTnI 144 -173 ) at the two different pH values. The CSP of the amide NHs for these titrations are shown in Supplementary material online, Figure S2 along with their respective fitting curves, and the results are summarized in Table 1 . The affinity of the native cardiac peptide at pH 6 is roughly half of its affinity at pH 7. Thus, the presence of H162 in the mutated peptide makes binding at pH 7 tighter than that of native peptide at pH 7 by a factor of 5 and 20 times tighter than that of native peptide in acidic conditions. These observations are in agreement with those made at cellular and organ level for the cTnI A164H studies performed in transgenic mice, where the beneficial effects of the substitution are evident at both normal and acidic conditions, but much more at acidic pH. 10 An acidic environment improves binding of the mutated peptide by a factor of 4, which is comparable with a factor of 3.6 improvement on binding for the skeletal isoform in acidic conditions. 12 3.2 Determination of pK a of aspartate and glutamate residues of cNTnC . Ca 21 The observed pH-dependent change in the affinity of the mutated peptide suggests that protonation of H162 at the lower pH is important to the binding affinity. N correlation spectra by tracking the CSP of the amide NHs as a function of the pH; backbone hydrogen atoms located in non-titratable residues can be sensitive to and indicative of intramolecular hydrogen bonding between carboxylate groups and backbone amide protons. 25, 26 However, the carboxyl group chemical shift is a more direct indicator of the pK a because it is the group that is being ionized (or protonated). The 2D carboxyl 1 H, 13 C spectrum correlates the aliphatic protons with the carboxyl carbon of glutamate and aspartate residues of cNTnC. The distribution of glutamate and aspartate residues in cNTnC is depicted in Supplementary material online, Figure S3 . We focused on E19 and E15, as they are the closest negatively charged residues (,3 and ,10 Å , respectively) to H130 in the homologous sTnI structure, and E55 as a control since it is far away. Figure 2 shows the CSP of the backbone NHs of E19 and E55 (panels A and B) and the carboxyl groups (panel C) of E15, E19, and E55 in cNTnC . Ca 2+ when bound to cTnI 144 -170 A162H. The 1 H and 15 N resonances of E55 show a linear behaviour of CSP typical for a single-dissociation event. E19, on the other hand, shows an unusual curved change in the amide proton shift as the pH changes ( Figure 2B ), which indicates a dependence on two different acid dissociation events. E15 is located in a highly overlapping region in the 1 H, 15 N correlation spectra, and cannot be reliably tracked (Figure 2A) . In the 2D carboxyl 1 H, 13 C spectra (Figure 2C) , the indication of two dissociation events is not obvious for E19 but is revealed in the fitting of the data (see below). One of the gamma hydrogen atoms of E15 moves earlier in the titration, reflecting a higher pK a than the typical for a glutamate residue (see fitting below). E55 shows linear CSP with the pH variations characteristic of a single-dissociation event.
The same sets of experiments were repeated for the native complex, cNTnC . Ca 2+ . cTnI 144 -173 . In this case, E15, E19, and E55 all show linear CSP on their proton, nitrogen, and carbon resonances (Supplementary material online, Figure S4 ) indicative of singleprotonation events for each of these residues. These results imply that the unusual behaviour of E19 and E15 in the A162H complex are directly linked to the presence of H162, and provide evidence for an interaction being formed between H162 and E15 and E19. In order to address this possibility further, the pK a values of each residue were calculated. The 1 H, 15 N, and 13 C NMR chemical shifts of the NH, CH 2 , and CO atoms in the 2D spectra were fitted to monophasic or biphasic pK a curves, depending on whether one or two titration events were observed. The results for the native and A162H complexes are shown in Figure 3 . Reference pK a values for glutamate residues are estimated to range from 4.3 to 4.5 in oligopeptides and from 4.1 to 4.6 in proteins. 27 The observed pK a for E55 in this study was typical, always fit with a single pK a , and remained constant in the presence or absence of H162 (4.6 + 0.04 vs. 4.5 + 0.14). The pK a of E15 was also always fit with a single pK a , and not significantly altered (from 4.10 + 0.38 to 4.55 + 0.30) (the fitting errors are the largest for E15, because it has the lowest pK a and we were unable to go below pH 4.1 in our titrations because of the solubility of cTnC) by the presence of H162. However, the H g2 resonance of E15 showed a pK a value of 3.8 + 0.38 in the wild-type complex, but a much higher pK a value In contrast, four of the E19 resonances showed biphasic curves in the presence of the mutated cTnI 144 -170 A162H peptide; for these, an average pK a value of 4.7 + 0.11 is observed corresponding to the protonation of the carboxyl group in addition to an average higher pK a value of 6.83 + 0.25. The lower pK a is decreased from that observed in the absence of H162. Therefore, both E15 and E19 are sensing the protonation of a residue with a pK a of 6.8, and given the amino acid sequence of the peptides of interest and that this effect is only observed in the presence of the mutated peptide, this residue is most likely H162. The pH-dependent CSP of aspartate residues D2, D3, D25, D33, D87, and D88 of cNTnC when bound to the mutated and native peptide were also followed. Because the typical pK a value for aspartate residues is low (3.8 -4.1 27 ), determination of their pK a values was difficult due to poor solubility of troponin below pH 4.1. The data are shown in Supplementary material online, Figure S5 ; in all cases, the overlap between pairs of data points indicates identical titrations, and differences are only observed in the lower pH region of the fitting curves. D3 displays a biphasic curve in both complexes with the second pK a higher than typical for a histidine residue. The second protonation event is attributed to the NH 3+ at the N-terminus. D25 and D33 do not yet display significant CSP at the lowest pH tested-this indicates that they have even lower pK a values. None of the aspartate residues are in close proximity to the site of interest (Supplementary material online, Figure S3 ).
Determination of pK a for H162 and H171
To determine whether the higher pK a value associated with E15 and E19 corresponds to that of H162, we determined the pK a value for this residue in the cTnI 144 -170 Figure 4A and B, respectively. The signals corresponding to hydrogens H2 and H5 of H162 are indicated-the large pair of signals seen in both sets of experiments corresponds to hydrogens H4 and H5 (large upfield signal) and H2 (large downfield signal) of imidazole used to measure the pH of the sample at each titration point. Signals from the amide hydrogens of the protein and the peptide can also be seen in the aromatic region. In the spectra Residues E15, E19, and E55 are labelled. E15 in the 2D 1 H, 15 N correlation spectra is located in a highly overlapping region (green dot in A).
Interaction of cNTnC with cTnI A162H
corresponding to the cNTnC . cTnI 144 -170 A162H complex, this set of signals become more intense and better resolved as the pH decreases as a result of reduced chemical exchange of the amide hydrogen atoms. 28 Fitting of the CSP of the hydrogen atoms H2 and H5 of H162 as a function of pH in the absence ( Figure 5A ) and presence ( Figure 5B ) of cNTnC results in average pK a values of 6.28 + 0.02 in the free form and 6.34 + 0.03 in the 25% bound form. The pK a value of the fully bound form can be extrapolated since the observed NMR signals of protons H2 and H5 are in fast exchange and represent a weighted average signal with contributions from the bound and the excessive free forms. Furthermore, since the binding of cTnI 144 -170 A162H is sufficiently tight at both acidic and alkaline pH values (Table 1) , the fraction bound does not substantially change during the pH titration. The extrapolated value for the fully bound form is 6.52 + 0.24, which is consistent with the additional value observed for E15 and E19, within the range of error (6.80 + 0.31 and 6.83 + 0.25, respectively).
The same procedure was followed to determine the pK a value of H171 in the native peptide in the free state. For the bound form, the dependence of K D on the pH was taken into account as previously described. 12 The results (Supplementary material online, Figure S6) indicate a pK a range of 6.43 to 6.46 for the bound form, which is not sensed by any other glutamate (Figure 3 , black) or aspartate (Supplementary material online, Figure S5 ) residue in cNTnC.
Discussion
In the structure of the Ca 2+ -saturated cardiac troponin core complex, 29 the switch helix of cTnI that makes contact with cNTnC stretches from residues 144 to 160; residue A162 is in a linker region which connects to a C-terminal a-helix that has been shown to be intrinsically disordered in solution. 30 In the NMR structure of cNTnC . Ca 2+ . cTnI 147 -163, 22 residue A162 extends out of the hydrophobic pocket of cNTnC. In the structure of the Ca 2+ -saturated skeletal troponin complex, 31 the switch helix of sTnI is bound in a similar fashion except that residue H130 (corresponding to A162 in cTnI) makes contact with E20 in sNTnC . 2Ca 2+ ; and flexibility on that region starts at approximately residue 137 as shown by NMR relaxation studies. 32, 33 These structures are shown in Figure 5 . Our recent study of sTnI 115 -131 bound to cNTnC . Ca 2+ showed that an electrostatic interaction was formed between H130 of sTnI and E19 of cNTnC. 12 In this work, we used a mutant of cTnI switch peptide, cTnI 144 -170 A162H, to test whether this single mutation is solely responsible for a stronger interaction between cTnI and cTnC, and whether the naturally occurring H171 could play a similar role. The present data indicate an electrostatic interaction between E15 and E19 with H162 in cTnI, whereas H171, downstream from A162, makes no observable interaction with cNTnC . Ca 2+ .
We demonstrated that H162 in the cTnI 144 -170 A162H peptide is in close proximity of the two glutamate residues in cNTnC, E15 and E19, since both are sensitive to the protonation of H162 and exhibit deviations in their pK a profiles displaying a high pK a value of 6.8. We observed biphasic pK a curves for most of E19 resonances; the same profile of biphasic curves was seen for the gamma proton of E19, but not for E15, when cNTnC . Ca 2+ is bound to sTnI 115 -131
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-in this case, the X-ray structure for the skeletal structure 31 ( Figure 5A ) confirms the close proximity (3 Å ) of nitrogen 3 in H130 with oxygen 1 of E20 (analogues of H162 and E19, respectively); in the same structure, E16 (analogue of E15 in cTnC) is too far away from H130 (.10 Å ). Determination of the pK a value of H162 when cTnI 144 -170 A162H is fully bound to cNTnC (6.5 + 0.24) provides evidence that the protonation event sensed by E15 and E19 corresponds to H162 in the mutated peptide and confirms the electrostatic interaction between them. This was verified by investigating the pK a values for S.E. Pineda-Sanabria et al.
the native complex cNTnC . Ca 2+ . cTnI 144 -173 , which show monophasic curves for all the resonances of E15, E19, and E55 with no indication of close proximity to another titratable residue despite the presence of H171 in the native switch peptide. This observation, along with the weak binding observed for the native peptide, also indicates that H171 does not play any role in the isoform-dependent pH sensitivity of the cardiac thin filament. The fact that E19 experiences a drop in pK a with the presence of H162 further confirmed their electrostatic interaction. Neutralization of the negative charge of E19 by interaction with the positive charge of H162 would cause an increase in its electrostatic potential for which a lower pK a is expected according to the trend of decreasing pK a values with increasing electrostatic potential observed for aspartate and glutamate residues in proteins. 27 This shift of a pK a to a more acidic value was also observed for the cNTnC . Ca 2+ . sTnI 115 -131 complex and confirms the electrostatic interaction between E19 and H162. Regarding the possibility of salt bridge formation, we considered protonation of N1 in the skeletal structure ( Figure 5A and C 
where R is the gas constant (8.314 Jmol 21 K
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) and T is the absolute temperature. The results are summarized in Supplementary material online, Table 1S . DDG between the mutated and native peptides at pH 7 (20.9 kcal/mol) corresponds to an estimate of the stabilization energy of the hydrogen-bond component contributed by the proton donor H162 in the neutral state. DDG for the binding of the mutated peptide to cNTnC between pH 6 and 7 (20.9 kcal/mol) corresponds to additional stabilization energy from the charge -charge interaction between E15/E19 and H162 once the pH drops. This explains the observations done at the molecular level in the present study, and at cellular and organ levels shown previously, that the A162H mutation shows improvement from basal conditions, which is further enhanced under acidosis.
We estimate that the contribution of the salt bridge made by H162 at low pH is 2.2 kcal/mol. This value is not identical to the sum of the individual components of the salt bridge (hydrogen bond + Interaction of cNTnC with cTnI A162H charge -charge ¼ 21.8 kcal/mol) because of the length difference between the mutated and native peptides that may affect the binding affinity.
Our hypothesis is consistent with the reported DDG of 20.9 kcal/ mol 12 for sTnI binding to cNTnC . Ca 2+ at pH 6.1 and 7.5, and with computational alanine scanning performed for the cTnC . ssTnI complex, where the DDG caused by alanine substitution was calculated for residues at the cTnC . ssTnI interface. The study calculated a DDG of 0.91 kcal/mol for E19A cTnC when binding to sTnI and 2.46 kcal/mol for H132A ssTnI when it binds to cTnC. 13 Thus, we speculate that the E19A substitution leads to a smaller destabilizing effect because the presence of E15 that may make weak electrostatic interactions with H162, E19A may introduce new hydrophobic stabilizing contacts with the aromatic ring of H162, and/or the H132A substitution may interrupt interactions with D121 that stabilize the proper conformation of ssTnI.
Regarding the role of other residues in TnI isoform dependence of myofilament function, it has been shown that N141 and V134 in ssTnI (H171 and E164 in human cTnI) partially influence the isoformspecific contractile function in rat cardiac myocytes expressing ssTnI, and are involved in modulating the Ca 2+ sensitivity at physiological and acidic pH, respectively. 35 When the N141H substitution is introduced to ssTnI, the Ca 2+ sensitivity of the myofilaments becomes comparable with that of cTnI but the pH sensitivity remains similar to that of ssTnI. Considering that our present results show no role of H171 in regulating pH sensitivity, this implies that N141 is responsible for the Ca 2+ sensitivity difference between cTnI and ssTnI at physiological pH, and that H132 is solely responsible for the reduced pH sensitivity observed for ssTnI N141H. We predict that the reverse substitution introduced in the cardiac isoform (cTnI H171N) would show increased Ca 2+ sensitivity at physiological pH but would still be sensitive to acidosis. For V134, if H162 of mutated cTnI in the present study is located close to E15 and E19 in cNTnC, and H130 close to E19/E20, 12,31 mutation to the cardiac analog (V134E) introduces unfavourable interactions with cNTnC since V134E would also be in the vicinity of the same negatively charged glutamate residues ( Figure 5A ). Therefore, V134 may have shown a role in modulating Ca 2+ sensitivity by reducing unfavourable interactions between ssTnI and cNTnC. In cardiac muscle, the absence of H162 in cTnI and the consequent increased local flexibility prevent close cTnI -cNTnC interactions in that region such that the effect of the reverse mutation (cTnI E164V) in pH sensitivity would either be small or negligible. The estimated stabilizing effect of A162H on the cTnI-cNTnC interaction (22.2 kcal/mol) is close to the destabilizing effect of low pH in Ca 2+ binding (2.4 kcal/mol). 36 This supports our previous theory that Ca 2+ binding to cNTnC at low pH is partially compensated by stronger binding of the cTnI switch peptide. However, the stabilizing effect of H162 is still much larger than the stabilization induced by the calcium sensitizer, dfbp-o (20.5 kcal/mol), 15 which highlights the necessity for the development of more potent cardiotonic agents to treat heart failure. Unlike other foetal contractile proteins, ssTnI with constitutive H130 (corresponding to residue 162 in cTnI) is not re-expressed in the failing heart. Activation of the foetal cardiac gene programme is a hallmark of hypertrophy and heart failure; the expression of the foetal isoform of the contractile proteins skeletal a-actin and b-myosin heavy chain is re-induced, 37, 38 but not that of ssTnI as shown for hypertrophic rat hearts and end-stage failing human hearts. 39, 40 This study could be useful for the design of novel therapeutic agents for the treatment of myocardial ischaemia and heart failure as it reveals the location and nature of the additional cTnIcNTnC interactions promoted by H162 and an estimation of the energy required to stabilize the cTnI-cNTnC interface during acidosis.
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